Cidara doses first group in phase 1 trial of CD388 for treating/preventing influenza
01 April 2022 - 12:53AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Apr 2024 to May 2024
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From May 2023 to May 2024